GlassScriptPhysician profile
Brian C Beatty
NPI 1447253638
$1,967.53
in general payments reported to CMS, 2019-2025
24 companies · $68.25 in 2025
The $68.25 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $120 · 2021: $313 · 2022: $473 · 2023: $361 · 2024: $466 · 2025: $68.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.64 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.50 | 2019-2024 | Lo Loestrin Fe |
| Astellas Pharma US INC | $404.12 | 2022-2024 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $181.96 | 2021-2024 | Ova1 |
| Pfizer INC. | $133.03 | 2019-2024 | |
| Hologic Sales and Service, LLC | $106.55 | 2019-2024 | Aptima |
| Novo Nordisk INC | $88.05 | 2021-2023 | Wegovy |
| Olympus America INC. | $79.01 | 2021-2025 | Gyrus Acmi, Olympus |
| Daiichi Sankyo INC. | $75.61 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $71.81 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $56.52 | 2022-2023 | |
| Therapeuticsmd, INC. | $46.71 | 2020-2022 | |
| Gynesonics, INC. | $34.74 | 2022 | |
| Millicent US INC | $31.71 | 2022-2023 | Intrarosa, Femring |
| International Rehabilitative Sciences, INC | $30.21 | 2022 | |
| Avion Pharmaceuticals | $26.15 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $25.09 | 2025 | Myfembree |
| Medtronic, INC. | $22.24 | 2025 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $19.71 | 2022 | |
| Organon LLC | $17.79 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.29 | 2023 | Seglentis |
| Ascend Therapeutics US, LLC | $16.50 | 2019 | |
| Exact Sciences Corporation | $13.85 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $12.80 | 2022 | |
| Allergan, INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.